Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Watchman21on Dec 31, 2021 12:22pm
105 Views
Post# 34274092

RE:RE:realistically....

RE:RE:realistically.... Crazy to read people stating COVID19 is going away... Its not...  We watch in hope as it disipated over the summer to come charging back with Delta, and now Omicron.    

Anyway, Siemen and Roche timelines to FDA EUA , based on all the stduies and tests they did around the world, is both crazy and embarrassing that it took them so long to get on this FDA EUA list.  


Roche did tests in all these nations - Germany, Netherlands, Italy, Switzerland, Finland, Denmark, Brazil, Mexico, Hong Kong, Thailand, Japan - All completed in March 2021 for this April 2021 Report.  USA study was performed in 5 clinics and probably just completed in November 2021, but most likely started months before that.  

THRM has 3 clinics and probably be done within a month timeframe, so why all the concern?  

Go ahead...download this Roche’s SARS CoV2 Rapid Antigen Test Study…. It just confirms U.S.A.’s FDA is truly the Gold Standard and probably the toughest evaluator in this space…
 

SARS-CoV-2-Rapid-Antigen-Assay-Clinical-Performance ...https://diagnostics.roche.com › dam › pdf › cps

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse